« Return to News | Study Conduct

NPR Interviews David DeMets on Drug Safety Monitoring Boards

Tuesday, June 13, 2006 11:04 AM

In the wake of Vioxx and the recent events during the German biotech TeGenero AG’s trial, involving a severe immune reaction in six British subjects given an investigative monoclonal antibody, the industry has made a major effort to review trial safety precautions. Among other areas under scrutiny, the work of independent review boards (IRBs) has received much attention. Recently, the roles and challenges of Data Safety Monitoring Boards (DSMBs) have also been discussed in preventing further safety issues during clinical trials AND after market approval...

Hoping to shed some light on the subject, National Public Radio (NPR) recently conducted an interview with David DeMets, the chairman of the Department of Biostatistics and Medical Informatics at the University of Wisconsin. DeMets has also authored of several books on trial monitoring, and co-edited the book “Data Monitoring in Clinical Trials: A Case Studies Approach” with Dr. Curt Furberg Professor at the Department of Public Health Sciences at Wake Forest University and Dr. Lawrence Friedman is a former Director of the Division of Epidemiology and Clinical Applications at the National Heart, Lung, and Blood Institute.

The complete interview can be read on the NPR website.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.